FIELD: medicine, veterinary science. SUBSTANCE: invention proposes an ointment containing a complex of proteolytic enzymes showing collagenolytic activity obtained from king crab hepatopancreas, anesthetic agent, distilled water, bacteriostatic, buffer addition and a base. Collase is used as the complex of proteolytic enzymes and polyethylene oxide gel - as a base at the following ratio of components, wt.-%: collase 0.01-0.1; anesthetic agent 2.0-5.0; buffer addition 0.05-0.7; bacteriostatic 1.0-3.0; distilled water 4.0-7.0 and polyethylene oxide gel - the rest. Trimecain is used as an anesthetic substance, potassium hydroxide - as a buffer addition and boric acid - as a bacteriostatic. An agent can be used for treatment of humans and animals with suppurative-necrotic wounds and burns. EFFECT: enhanced effectiveness of an agent. 2 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF COLLASE PURIFICATION | 1996 |
|
RU2121503C1 |
AGENT FOR SKIN CARE | 1994 |
|
RU2089177C1 |
HYALURONIC ACID-BASE PHARMACOLOGICAL AGENT SHOWING ANTIBACTERIAL, WOUND-HEALING AND ANTI-INFLAMMATORY EFFECT | 1999 |
|
RU2195262C2 |
ANTIVIRAL PREPARATION FOR EXTERNAL APPLICATION BASED UPON HYALURONIC ACID | 1999 |
|
RU2178693C2 |
COMPOSITION FOR TREATMENT OF SUPPURATIVE-NECROTIC WOUNDS (VARIANTS) | 1997 |
|
RU2150936C1 |
AGENT FOR TREATMENT OF SUPPURATIVE-NECROTIC PROCESSES | 1998 |
|
RU2145497C1 |
SUBSTANCE OF PROTEOLITHIC FERMENT BASED ON PROTOSUBTILIN GZH IMMOBILIZED ON CHITOSAN AND COMPOSITION FOR TREATMENT OF PURULENT-NECROTIC WOUNDS | 2016 |
|
RU2630668C1 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
ALPHA-2-INTERFERON-BASED ANTIVIRAL AGENT IN CREAM FORM | 1998 |
|
RU2159609C2 |
METHOD OF TROPHIC ULCER TREATMENT | 1992 |
|
RU2057534C1 |
Authors
Dates
1999-10-10—Published
1997-12-16—Filed